When Dr. Daniel Vasella learned about the early results of the Phase 1 trial, he immediately decided what course of action to take Novartis. Students will have the opportunity to explore and assess the specific steps and their rationale that Novartis has taken in response to this challenge. Focuses not on morality against immorality, but for the principal decision-making, actions, and the practical consequences of making good on a moral decision. "Hide
by Sandra J. Sucher Stacy McManus Source: Harvard Business School 18 pages. Publication date: April 15, 2003. Prod. #: 603044-PDF-ENG
Related Case Solutions & Analyses:
Managing in Different Growth Contexts
Can Innovation Be Lean
Dragonfly Corporation
Everything or Nothing: Martti Ahtisaari and the Aceh Negotiations (B)
Fortis Industries Inc. (A)
In Search of the Secrets to Longevity
The World Food Programme during the Global Food Crisis (B)
La Fageda
Interview with Rob Smith Senior Partner of Davis Langdon (Video) DVD
Kohl Industries
